Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2017 (2017), Article ID 7176816, 4 pages
https://doi.org/10.1155/2017/7176816
Case Report

Lung Volume Reduction following Recurrent Pneumonia: An Unusual Finding in a COPD Patient

Division of Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA

Correspondence should be addressed to Yihenew Negatu; moc.oohay@0891szay

Received 28 October 2016; Revised 9 February 2017; Accepted 23 February 2017; Published 8 March 2017

Academic Editor: Florian Thalhammer

Copyright © 2017 Yihenew Negatu and Philip T. Diaz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Global Initiative for Chronic Obstructive Lung Disease, “Global strategy for diagnosis, management and prevention of COPD,” 2016.
  2. S. Sethi and T. F. Murphy, “Infection in the pathogenesis and course of chronic obstructive pulmonary disease,” New England Journal of Medicine, vol. 359, no. 22, pp. 2312–2365, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Fletcher and R. Peto, “The natural history of chronic airflow obstruction,” British Medical Journal, vol. 1, no. 6077, pp. 1645–1648, 1977. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Vestbo, L. D. Edwards, P. D. Scanlon et al., “Changes in forced expiratory volume in 1 second over time in COPD,” New England Journal of Medicine, vol. 365, no. 13, pp. 1184–1192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. R. E. Kanner, N. R. Anthonisen, and J. E. Connett, “Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the Lung Health Study,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 3, pp. 358–364, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. G. C. Donaldson, T. A. Seemungal, A. Bhowmik, and J. A. Wedzicha, “Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease,” Thorax, vol. 57, pp. 847–852, 2002. View at Google Scholar
  7. H. E. Fessler, S. M. Scharf, E. P. Ingenito, R. J. McKenna Jr., and A. Sharafkhaneh, “Physiologic basis for improved pulmonary function after lung volume reduction,” Proceedings of the American Thoracic Society, vol. 5, no. 4, pp. 416–420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Fishman, F. Martinez, K. Naunheim et al., “A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema,” New England Journal of Medicine, vol. 348, no. 21, pp. 2059–2073, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Reilly, G. Washko, V. Pinto-Plata et al., “Biological lung volume reduction: a new bronchoscopic therapy for advanced emphysema,” Chest, vol. 131, no. 4, pp. 1108–1113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. E. P. Ingenito, R. L. Berger, A. C. Henderson, J. J. Reilly, L. Tsai, and A. Hoffman, “Bronchoscopic lung volume reduction using tissue engineering principles,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 5, pp. 771–778, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. G. J. Criner, V. Pinto-Plata, C. Strange et al., “Biologic lung volume reduction in advanced upper lobe emphysema phase 2 results,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 9, pp. 791–798, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Refaely, M. Dransfield, M. R. Kramer et al., “Biologic lung volume reduction therapy for advanced homogeneous emphysema,” European Respiratory Journal, vol. 36, no. 1, pp. 20–27, 2010. View at Publisher · View at Google Scholar · View at Scopus